Introduction
The recent explosion of knowledge regarding lymphocyte and dendritic cells (DC) trafficking has shed light on the mechanism of normal primary immune responses. [1] [2] [3] [4] [5] Both naive T cells, and the more recently identified subset of central memory cells, express L-selectin, CCR7, and LFA-1, and are particularly efficient at entering lymph nodes (LN) from blood by extravasating through high endothelial venules (HEV) that bear peripheral node addressin (PNAd), SLC/CCL21, and ICAM-1. 6 Once in the LN, these T cells migrate via CCR7-mediated pathways to T-cell-rich areas of the LN. In this microenvironment, antigen presentation by mature DC that have arrived in LN from tissue via afferent lymphatics can occur in an efficient manner. Thus, the LN microenvironment enhances the likelihood that antigen-loaded DC will encounter naive and central memory cells. In contrast, antigen-loaded DC in peripheral tissues at extranodal locations are more likely to encounter effector memory T cells.
Against this background, the use of DC in clinical medicine, particularly in vaccine therapy for the induction of new primary immune responses, or responses that activate central memory cells, becomes potentially problematic. Based on the above trafficking paradigms, delivering DC in significant numbers from blood directly to the LN by conventional approaches would be difficult, as most mature DC lack at least one member of the triad of molecules required to gain access to LN: L-selectin, CCR7, and LFA-1. Indeed, delivering DC to LN from blood has been impossible to achieve thus far in clinical studies. When administered subcutaneously or intradermally, only a fraction of the injected DC can be demonstrated to traffic via afferent lymphatics to draining LN, while most remain in the tissue. 7 Intravenous injection of DC leads to their accumulation in lungs and peripheral tissue, but not in LN. [7] [8] [9] Although mature DC express two key molecules involved in HEV extravasation (CCR7 and LFA-1 1, 10 ), our data suggest that their exclusion from LN extravasation may be in large part because they lack L-selectin. While direct injection of DC into accessible LN is feasible, if technically challenging, 11 there is concern that the architecture of the node, including chemokine gradients, is massively disrupted by this approach.
Our goal in the present study was to develop approaches to delivering DC directly from the blood into the LN. If we could achieve this end, we reasoned, DC injected intravenously could be delivered to a variety of LN throughout the body, where their likelihood of encountering the maximum number of naive and central memory cells would be the greatest. In the present study, we demonstrate that by transducing cultured DC with a chimeric selectin comprising the extracellular domain of the endothelial selectin, E-selectin, 12 and the cytoplasmic and transmembrane domain of L-selectin, 13 E/L-selectin (ELS), DC that tether and roll on PNAd could be generated. These genetically modified DC were also observed to tether, roll, and stick onto postcapillary venules in lymph node (HEV) under intravital microscopy. Finally, when selectin-transduced DC and mocktransduced DC were mixed and injected into the bloodstream, only the ELS-transduced DC could be found in LN after 8 and 18 h.
Thus, these data suggest a simple and straightforward means of modifying mature DC migration by gene therapy in a way that allows them to traffic to LN throughout the body as a means of maximizing the efficiency of immunization. This approach may represent a major step forward in DC vaccine therapy.
Results

Ex vivo generated DC do not express L-selectin
The interaction between leukocyte L-selectin and its ligand on HEV, PNAd, is the first and mandatory step of a multistep adhesion cascade leading to extravasation of lymphocytes into PLN.
14 Since high expression levels of L-selectin are required to mediate interaction with endothelial cells, 10 we determined the expression of Lselectin on in vitro cultured DC. Neither human DC derived from cord blood or monocytes nor bonemarrow-derived murine DC showed significant expression of L-selectin ( Figure 1 ). Consistent with this phenotype, none of these DC populations were capable of interacting with immobilized PNAd in a parallel plate flow chamber assay. In contrast, murine peripheral lymph node cells, containing L-selectin positive naive T cells, express abundant L-selectin.
Retroviral transduction of DC with a PNAd ligand
In an attempt to endow DC with a functional HEV ligand, we constructed two retroviral constructs expressing full-length human L-selectin or the ELS chimera.
This latter chimera consists of the entire ectodomain of the endothelial selectin, E-selectin 12 and that of L-selectin transmembrane and intracellular domains 13 ( Figure 2a ). We were not successful in achieving sustained cell surface expression of L-selectin, the physiological PNAd ligand, on DC. The ectodomain of L-selectin contains a membrane-proximal cleavage site, 15 and it is possible that mature DC express an active protease that cleaves retrovirally expressed L-selectin from the surface. However, chimeric ELS is resistant to proteolytic cleavage (UH von Andrian, unpublished data) and stable cell surface expression of ELS was achieved on 30-40% of the transduced DC (Figure 2b and c). Our previous work has shown that the cytoplasmic and transmembrane domains of L-selectin determine the microvillous distribution of the selectin, 13 a feature that enhances contact initiation with ligands and provides optimal conditions for endothelial tethering and rolling efficiency. 13 Recent experiments with ELS-transfected murine pre-B cells have shown that ELS, unlike E-selectin, is clustered on the tips of microvilli and mediates efficient slow rolling in lymph node HEV in vivo. 10 In these studies, LVSEM was used to demonstrate this microvillous clustering. Ultrastructural immunolocalization of the transduced chimeric ELS was assessed using precisely the same LVSEM approach (Figure 2d ). Immunogold particle distribution on three representative transformed DC indicated that 80-95% of particles were associated with microvilli, and that 75% of these microvillous particles were found on the upper half and the tip of surface projections. There was no detectable staining by the anti-E-selectin MAb on cells transduced with a retroviral control vector expressing GFP and no binding was detected on transformed cells when an isotype-matched nonbinding control antibody was used (not shown). Thus, we demonstrate that detectable levels of a known PNAd counter-receptor that has an optimal topographic distribution to initiate rolling interactions in HEV can be expressed on the DC surface.
ELS-transduced DC tether and roll on PNAd in vitro and in vivo
We next assessed the functional properties of ELS expression using a parallel plate flow chamber assay. The mean ELSmediated rolling velocity (5 mm/s) was eight times slower than the mean L-selectin-mediated rolling velocity on PNAd (40 mm/s). This is in accordance with previous studies showing that E-selectin/PNAd interactions permit much slower rolling velocities than conventional Lselectin/PNAd interactions. 10 Since slow rolling in other tissues has been shown to facilitate integrin activation in response to endothelial chemoattractant stimuli, 17, 18 it seems likely that slow rolling of DC on HEV could favorably influence the subsequent extravasation steps.
Using a system recently developed to study subiliac lymph node microcirculation, we also studied DC-HEV interactions in vivo by intravital microscopy. 19 After retrograde injection of calcein-labeled DC into the right femoral artery, we measured tethering and rolling of ELS-transduced as well as GFP-transduced DC in the downstream left subiliac LN. Figure 3b shows the results obtained in 14 venules from three mice. Rolling fractions of GFP-and ELS-transduced DC in each venule, and the mean rolling fractions for each cell type in the distinct venular branching orders II, III, and IV microvessels are shown. The mean rolling fraction of GFP-DC was very low (2.09%72.04), while ELS-transduced DC rolled much more frequently (mean rolling fraction in all venules: 11.97%76.11) (Po0.0003) (Figure 3b ). This confirms that ELS is a functional HEV ligand in vivo.
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As anticipated, the rolling fraction of ELS-DC was highest in the most distal venules (fourth-order venules), where the expression of PNAd is more abundant and the narrower venular diameter favors frequent collision between DC and the vascular wall. 20 In a population of stably transfected pre-B cells that expressed high levels of an efficient PNAd ligand, the rolling fraction observed 13 was cloned into the insertion site of CMMP retrovirus. 27 (b) After retroviral infection, murine bone-marrow-derived DC were stained with an FITC-conjugated anti-human E-selectin monoclonal antibody and a PE-conjugated anti-murine class II monoclonal antibody. More than 40% of the cells express both the class II and the chimeric ELS molecules. This transduction efficiency was reproducibly obtained upon multiple repetitive experiments. (c) Infected DC are observed using phase confocal microsopy and confocal fluorescence microscopy (FITC channel) ( Â 100). ELS-infected DC are stained with an FITCconjugated anti-human E-selectin monoclonal antibody and observed using phase confocal microscopy and confocal fluorescence microscopy. Transduced DC express ELS on their surface and are visualized by the green peripheral fluorescence. (d) Low-voltage scanning electron microscopy of a part of the surface of a CMMP-ELS-transduced DC. Colloidal gold particles were combined to an anti-human anti-E-selectin antibody. Most of the ELS-chimera expression is found on the upper parts of the microvilli.
Gene therapy to target dendritic cells C Robert et al in vivo rarely exceeded 35%. 10 Since only 30-40% of our transduced DC expressed ELS, we expected B35% of this population to tether (that is, 10.5-16% of the total input population). The observed mean rolling fraction of 11.97% is consistent with this prediction, and indicates that our ELS-DC could tether and roll in HEV with very high efficiency.
ELS-transduced DC stick onto HEV
Cells that stick on vessel walls after rolling are assumed to have been activated via chemokines and to adhere via LFA-1/ICAM-1 interactions. 2, 5 Sticking cells, defined as cells arrested for at least 30 s along the endothelial wall, were counted and expressed as sticking efficiency, that is, the percentage of the total flux of cells passing through a defined venule (Figure 3c ). The sticking fraction of the subpopulation of cells that initiated rolling in HEV (Figure 3d ) was also determined. In the 14 venules observed, almost no control cell could undergo firm adhesion (mean sticking fraction: 0.037%70.0037%, whereas 2.2% 7 0.46% of ELS-transduced cells became stuck onto HEV (Po0.0059). There was also a significant difference between the sticking fraction of rolling adherent GFP-and ELS-transduced cells (1.0271 versus 13.1673.59%, Po0.002). This means that the tethering and rolling interaction mediated by ELS was far superior to the unidentified adhesion pathways responsible for very-low-frequency rolling of GFP-DC in their ability to facilitate firm adhesion on HEV. These results suggest that the much slower rolling afforded by ELS was indeed facilitating chemokine receptor engagement and integrin activation. Therefore, the choice of the chimeric ELS ligand, in addition to its resistance to proteolytic degradation, its optimal clustered expression on microvilli tips, and its ability to mediate very slow rolling, offers the advantage of facilitating the successful engagement of subsequent steps in the adhesion cascade.
ELS transduced DC but not control DC extravasate into PLN
To ensure subsequent extravasation of tethering, rolling, and sticking DC into the paracortical T-cell area, we directly tested the capacity of adoptively transferred DC to exit lymph node HEV from peripheral blood using confocal microscopy. GFP-transduced DC and ELStransduced DC were stained with green and red fluorescent cell tracker dyes, respectively. Cells were then mixed at a ratio of 1:1 (Figure 4a ) and injected into the bloodstream. Mice were killed 8 and 19 h later, and the presence of red and green fluorescent cells in tissue sections was determined. In the lung (Figure 4b ) and in spleen (not shown), both DC populations were found in approximately equal numbers. This is consistent with random extravasation and/or passive intravascular trapping in these tissues. In contrast, there was a clear preponderance of red (ELS-transduced) cells versus green (GFP-transduced) cells in peripheral lymph node sections (44 (range 33-60) versus 3 (range 2-4) per section) (Figure 4c and d) . Staining of HEV using a FITCconjugated anti-PNAd monoclonal antibody indicated that the labeled cells were localized in the extraluminal space, confirming that they had indeed migrated through the endothelial layer and entered the T-cell area ( Figure  4e) . Therefore, ELS-selectin-transduced DC were prefer- Freshly extracted cells from mouse-peripheral LN (ie mainly lymphocytes) (first column) were compared to murine bone-marrow-derived DC that were transduced with either CMMP-ELS (second column) or CMMP-GFP-transduced DC (third column) for their ability to interact on PNAd. The three cell populations were washed and resuspended at a similar concentration. They were then subsequently allowed to flow into the chamber at a physiological flow rate of 2 dyn/cm 2 . Lymph node cells and ELS-transduced DC tether and roll on the immobilized PNAd (mean numbers of rolling cells per field were respectively: 33710.8 and 54710.5), whereas almost no GFP-expressing DC could interact with PNAd (mean number of rolling cells: 271) (Po0.0002). (b) Mice were anesthetized and their left subiliac LN were prepared as previously described 30 allowing the direct visualization of infused cells in the lymph node microcirculation. Rolling fractions of GFP-or ELS-transduced DC labeled with calcein were analyzed in peripheral LN venules of different orders. A total of 14 venules belonging to three mice were observed. The rolling fraction, which is the percentage of rolling cells among the total cell flux, was subsequently determined in each individual venules for GFP-and ELS-expressing DC. Rolling fractions in the same venule are connected by straight lines. Bold lines represent the mean values. Rolling fractions of control (GFP-transduced DC) was always inferior to 5%. ELS-transduced DC rolling fractions were higher than the ones of control DC in every venule. The overall rolling fraction of ELS-DC (11.9%76.11%) was significantly superior to the one of the control cells (2.09%72.04) (Po0.0003). The highest rolling fraction was found in the fourth-order venules, where the expression of PNAd is more abundant. Gene therapy to target dendritic cells C Robert et al entially recruited to extravasate through HEV in LN, presumably using a modification of the same three-step extravasation process used by naive T cells.
Discussion
In this report, we provide evidence that the migration of DC can be modified using a retroviral gene transfer technology. Expression of a functional and stable PNAd ligand enables DC to access to the immunogenic lymph node microenvironment from blood. The chimeric ELS protein offers three critical advantages over the naturally expressed L-selectin. First, it is stably expressed on DC surface and, unlike L-selectin, it is resistant to proteasemediated shedding from the cell. Second, it retains the selective expression on micovilli conferred by the cytoplasmic domain of L-selectin, which should enhance contact initiation with endothelial ligands. Finally, it mediates a significantly slower rolling velocity than Lselectin and thus facilitates endothelial firm adhesion once the DC are rolling on PNAd. 10 Our observation of the rolling and sticking characteristics of ELS-transduced DC is consistent with this last observation.
Our approach may have benefits to vaccination that are qualitative as well as quantitative. For example, an increasingly validated paradigm posits that the anatomic location of the LN where a naive T cell encounters its antigen dictates the homing properties of the effector/ memory T cells that emerge from this encounter. 2, 21, 22 Thus, a naive T lymphocyte that encounters its antigen in a skin draining LN proliferates and differentiates, upregulating the expression of skin homing adhesion molecules and chemokine receptors (CLA, CCR4, CCR10), allowing it to migrate to the skin. In contrast, antigen activation of naive T cells in a mesenteric LN leads to the appearance of gut homing molecules (eg, a4b7 integrin, CCR9) on the surface of the activated effector memory T cells, facilitating their further migration to lamina propria in the gut. 22 This homing paradigm might be critical in the context of immunotherapy. Indeed, a theoretical drawback of intracutaneous or intralymphatic DC injection in the setting of metastatic melanoma is the induction of antigen-specific effector T cells that preferentially home to skin, but may home less efficiently to other organs. Accordingly, when DC vaccination strategies have been successful in the setting of metastatic melanoma, it is cutaneous metastases that are most effectively cleared. 11, 23, 24 Therefore, in addition to the technical advantage of injecting DC directly into the blood versus into the skin or the LN, giving DC free access to peripheral LN from the bloodstream might actually broaden the repertoire of tissue-selective T-cell migration and improve the successful treatment of metastatic cancers, minimal residual disease, and disseminated infections.
Although we proved the principle that DC could reach LN from the blood following systemic injection, our experiments did not allow a precise quantification of the DC reaching the LN. Our approach certainly leaves room for modification and optimization. For example, DC migration to PLN could potentially be improved by increasing the ELS transfection efficiency and/or by increasing CCR7 expression on the DC surface. Next steps will include the study of the migratory phenotypes of antigen-specific T cells generated during cancer immunotherapy.
Harnessing the full potential of DC in medicine is an exciting goal, and one that has engaged the activities of a large number of investigators over the past decade. We believe that modifying the trafficking patterns of these cells is a potentially important step towards achieving this goal. Experiments that test the putative qualitative and quantitative advantages of direct delivery of DC from blood to lymph node are underway.
Materials and methods
DC culture
Human DC were generated both from CD34-and CD14-positive cells according to two previously described protocols. In the first protocol, 25 CD34 + cells were isolated from the mononuclear fraction of cord blood using magnetic beads (CD34 + isolation kit from Miltenyi Biotec GmBH, Bergish Gladbach, Germany) and Minimacs separation columns (Miltenyi Biotec GmBH). The isolated cells were 90-95% CD34 + . The cells were then cultured for 10-14 days in DMEM supplemented with 10% fetal bovine serum, 10 mM Hepes, 2 mM L-glutamine, 5 Â 10 À5 M 2-mercaptoethanol (Gibco), 100 U/ml penicillin, 100 g/ml streptomycin, IL-4 (50 U/ml R & D System), GM-CSF (1000 U/ml R & D System), TNF (50 U/ml R & D System), and Flt-3 ligand 100 ng/ml (Immunex Corp.).
In the case of the second protocol, 26 CD14 + mononuclear cells were isolated using magnetic beads (Miltenyi Biotec GmBH, Bergish Gladbach, Germany) and cultured for 7 days in DMEM supplemented with 10% fetal bovine serum, 10 mM Hepes, 2 mM L-glutamine, 5 Â 10 À5 M 2-mercaptoethanol (GIBCO), 100 U/ml penicillin, 100 g/ml streptomycin, IL-4 (1000 U/ml R & D System), and GM-CSF (1000 U/ml R & D System).
Murine bone-marrow-derived DC were obtained as previously described. 27 Bone marrow was flushed from the tibiae and femora of female 10-14-week-old C57B6 mice. Upon depletion of erythrocytes, the cells were cultured in DMEM supplemented with 10% inactivated fetal calf serum, 2 mM glutamine, 10 mM Hepes, 100 mM nonessential aminoacids, 100 U/ml penicillin, 100 mg/ml streptomycin, 5 Â 10 À5 M 2-mercaptoethanol (GIBCO), 500 U/ml recombinant murine GM-CSF, and 500 U/ml murine IL-4 (both from Sigma). On day 7 of culture, nonadherent cells with the typical features of DC were analyzed by FACS for the expression of the cell surface markers CD11c, CD80, CD86, MHC class II using commercially available monoclonal antibodies and appropriate isotype control antibodies (all from Pharmingen, San Diego, CA, USA). More than 90% of the cells showed high expression of these markers, while they were negative for expression of CD3, B220, and GR-1. In some experiments, the capacity of DC to initiate a mixed lymphocyte reaction was also confirmed (not shown).
Transduction of DC with retroviral constructs
Dendritic cells were transduced with CMMP-based VSV-G pseudotyped retroviral vectors as previously published. 27 The cDNA coding for human L-selectin, as well as the one coding for the chimeric ELS protein, which contains the intracellular and transmembrane domains Gene therapy to target dendritic cells C Robert et al of L-selectin and the extracellular portion of E-selectin, 13 were cloned into the insertion site of CMMP vectors matching the start codon with the env ATG. A green fluorescence protein (GFP) expression CMMP vector was constructed in parallel experiments and GFP-transduced DC that were subjected to the exact transduction protocol as ELS-transduced DC were used as a negative control cell population. For retroviral transductions, 10 ml of high titer viral particles (5 Â 10 8 -5 Â 10 9 ) were added to 1 ml of DC cultures on days 2 and 4 in the presence of polybrene 8 mg/ml. The DC were precooled, incubated with the virus at 41C for 3-4 h, and then transferred to 371C incubators. Expression of ELS by DC was tested by FACS and confocal microscopy using an FITC-conjugated antihuman anti-E-selectin antibody (Southern Biotechnology) and expression of L-selectin was tested using an anti-human anti-L-selectin (Coulter Corp).
Ultrastructural immunolocalization of retrovirally expressed ELS
Murine bone-marrow-derived DC transduced with ELS were stained with mouse-anti-human E-selectin mAb CL37 (gift from CW Smith, Baylor College of Medicine), washed and stained with 12 nm colloidal gold conjugated goat-anti-mouse antibody (dilution 1:6; from Jackson Labs). The cells were prepared for low-voltage scanning electron micrography (LVSEM) using a Hitachi S-900 LVSEM as previously published. 13 The surface distribution of colloidal gold particles was determined by analyzing micrographs at Â 80 000 magnification.
In vitro binding on PNAd
For in vitro rolling experiments, cell culture dishes were coated with a drop of 1/20 diluted affinity-purified PNAd from human tonsils. 28 The cells were resuspended in a medium containing 2 mM Ca + immediately before use, perfused into the chamber after blocking potential nonspecific binding with fetal calf serum for 15 min. The cells were allowed to interact with the immobilized PNAd under stepwise increasing flow shear stresses from 0.5 to 20 dyn/cm 2 . Nonspecific binding was assessed at the end of each rolling experiment by perfusing 5 mM EDTA in the chamber and counting the number of cells remaining bound to the coated PNAd.
In vivo rolling in lymph nodes
In vivo interactions of DC with high endothelial venules (HEV) were observed using intravital microscopy of subiliac LN preparations. 19 Mice were anesthetized by i.p. injection of xylazine (1 mg/ml) and ketamine (5 mg/ ml). The right femoral artery of each mouse was catheterized for retrograde injection of calcein-labeled cells and their left subiliac LN was carefully exposed by preparing an abdominal skin flap as described. 19 Mice were transferred to an intravital microscope (IV-500; Mikron Instruments) and LN microvessels were observed through a Â 10 or a Â 20 water immersion objective (Zeiss Achroplan, NA, USA). DC were labeled with calcein (3, 3 0 -bis[N,N bis(carboxymethyl)aminomethyl]fluorescein) (Molecular Probes, OR) at 2.5 g calcein/ml/10 7 cells and injected through the femoral artery in boluses of 20-50 l. This cell fluorescent dye is known for its good cell retention and its absence of interference with leukocyte adhesion and chemotaxis. 29 Injected cells were observed under fluorescence epiillumination from a xenon-arc stroboscope (Chaderick, Helmuth, CA, USA) in the contralateral exposed subiliac lymph node microcirculation. 19 This route of cell injection into the femoral artery allowed to keep the overall number of injected cells low and to minimize the number of recirculating cells entering the same LN. Thus, different types of transduced DC, that is GPP versus ELS-transduced DC could be subsequently injected and observed in the same venules. All experiments were recorded on Hi8 videotapes.
Rolling fractions were determined by off-line video analysis as the percentage of rolling cells among the total number of cells passing a venule during a recorded time interval. The venular tree in murine PLN consists of one or two collecting venules (order I) receiving blood from smaller collecting venules in the medulla (order II), which receive blood from midsize (order III) and small paracortical postcapillary venules (orders IV-V), the venular luminal diameter decreasing as the venular order increases. 19 Mean rolling fractions of GFP-DC and ELS-DC were analyzed for each venular order. Firm adhesion of cells, defined as a cellular arrest for at least 30 s in a physiologically perfused vessel, was also analyzed. Sticking was assessed using two different methods: the sticking efficiency represents the percentage of firmly adherent cells in the total number of cells passing through a venule, whereas the sticking fraction of interacting cells represents the percentage of rolling cells that became stuck (Figure 3d ). The former parameter provides information on the capacity of a given cell population that enters the LN circulation to undergo the entire three-step cascade while the sticking efficiency of interactive cells examines the capacity for integrin activation independent of the cells' ability to undergo tethering events. 30 
In vivo homing experiments
To study the capability of genetically modified DC to home from the blood directly to the PLN, ELS-and GFPtransduced DC generated from murine bone marrow as previously described and cultivated for 7 days were stained with 5-chloromethylfluorescein diacetate (CMFDA) and (5-(and-6)-(((4chloromethyl)benzoil)amino)tetramethylrodamine (CMTMR), respectively (both from Molecular Probes, OR, USA) according to the manufacturer's guidelines. Immediately prior to injection through the right femoral artery, both populations were mixed at a 1:1 ratio and 8 Â 10 6 of each cell population were injected. Two mice were sacrificed 8 and 18 h after DC infusion and the left subiliac and popliteal lymph nodes as well as lungs and spleen were harvested. Tissues were embedded into OCT Compound 4583 (Sakura, Torrance, CA, USA) and frozen in liquid nitrogen. Cryosections (5 m thick) of each tissue were fixed in 4% paraformaldehyde and visualized on an MRC-laser scanning confocal imaging system (Biorad). Excitation wavelengths were 488 and 522 nm, using emission filters of 522 and 598 nm. For in situ analysis, green and red cells were counted independently on each section. Some PLN sections were also stained with a CFSE-conjugated MECA-79 monoclonal antibody to localize the HEV. 20 Gene therapy to target dendritic cells C Robert et al
